Tech Company Financing Transactions
Amphivena Therapeutics Funding Round
Amphivena Therapeutics, based in San Francisco, received $38.7 million from private investors.
Transaction Overview
Company Name
Announced On
12/20/2018
Transaction Type
Venture Equity
Amount
$38,694,170
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 15 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Tower Pl. 1000
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to eradicate blood cancers with a breakthrough therapy that harnesses the patient's own immune system to destroy tumor cells and precursors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeanmarie Guenot
Chief Scientific Officer
Victoria Smith
VP - Bus. Development
Patrick Chun
VP - Operations
Amy Penticoff
Browse more venture capital transactions:
Prev: 12/20/2018: Prometheum venture capital transaction
Next: 12/20/2018: Waldo Photos venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs